BECTON DICKINSON & CO (BDX) Form 8-K — Jul 22, 2026
Dr. Michael D. Garrison, Executive Vice President and President of the Medical Essentials and BioPharma Systems segments, informed the company of his intention to retire after more than 20 years with the firm. He will remain in his role through the end of the fiscal year to support a smooth transition.
Price after filing
1 day: -0.1%7 days: +10.0%30 days: +22.5%
Close on the filing date to close N calendar days later (from $153.16). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.